According to Gland Pharma
's latest financial reports the company has a price-to-book ratio of 4.52042.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 3.33 | -12.8% |
2023-12-31 | 3.82 | 14.19% |
2022-12-31 | 3.34 | -65.24% |
2021-12-31 | 9.61 | -3.65% |
2020-12-31 | 9.98 |